Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Copeptin - A Biomarker to Improve Outcome Prediction in Patients With an Acute Psychotic Episode

NCT03235908 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT03235908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03235908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Copeptin - A Biomarker to Improve Outcome Prediction in Patients With an Acute Psychotic Episode
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Completed
Start date
May 1, 2017
Completion date
July 31, 2020
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute psychotic episode, affective disorder, bipolar disorder, schizophrenia spectrum and other psychotic disorders